231 related articles for article (PubMed ID: 19103464)
1. Decreased muscarinic receptor binding in the frontal cortex of bipolar disorder and major depressive disorder subjects.
Gibbons AS; Scarr E; McLean C; Sundram S; Dean B
J Affect Disord; 2009 Aug; 116(3):184-91. PubMed ID: 19103464
[TBL] [Abstract][Full Text] [Related]
2. The use of a modified [3H]4-DAMP radioligand binding assay with increased selectivity for muscarinic M3 receptor shows that cortical CHRM3 levels are not altered in mood disorders.
Jeon WJ; Gibbons AS; Dean B
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():7-12. PubMed ID: 23962466
[TBL] [Abstract][Full Text] [Related]
3. Changes in Muscarinic M2 Receptor Levels in the Cortex of Subjects with Bipolar Disorder and Major Depressive Disorder and in Rats after Treatment with Mood Stabilisers and Antidepressants.
Gibbons AS; Jeon WJ; Scarr E; Dean B
Int J Neuropsychopharmacol; 2016 Apr; 19(4):. PubMed ID: 26475745
[TBL] [Abstract][Full Text] [Related]
4. AMPA receptor expression is increased post-mortem samples of the anterior cingulate from subjects with major depressive disorder.
Gibbons AS; Brooks L; Scarr E; Dean B
J Affect Disord; 2012 Feb; 136(3):1232-7. PubMed ID: 22036795
[TBL] [Abstract][Full Text] [Related]
5. Lower cortical serotonin 2A receptors in major depressive disorder, suicide and in rats after administration of imipramine.
Dean B; Tawadros N; Seo MS; Jeon WJ; Everall I; Scarr E; Gibbons A
Int J Neuropsychopharmacol; 2014 Jun; 17(6):895-906. PubMed ID: 24495390
[TBL] [Abstract][Full Text] [Related]
6. An investigation of the factors that regulate muscarinic receptor expression in schizophrenia.
Seo MS; Scarr E; Dean B
Schizophr Res; 2014 Sep; 158(1-3):247-54. PubMed ID: 25037527
[TBL] [Abstract][Full Text] [Related]
7. Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment.
Crook JM; Tomaskovic-Crook E; Copolov DL; Dean B
Am J Psychiatry; 2001 Jun; 158(6):918-25. PubMed ID: 11384900
[TBL] [Abstract][Full Text] [Related]
8. Investigation of m1/m4 muscarinic receptors in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression disorder.
Zavitsanou K; Katsifis A; Mattner F; Huang XF
Neuropsychopharmacology; 2004 Mar; 29(3):619-25. PubMed ID: 14694353
[TBL] [Abstract][Full Text] [Related]
9. Levels of [(3)H]pirenzepine binding in Brodmann's area 6 from subjects with schizophrenia is not associated with changes in the transcription factor SP1 or BACE1.
Dean B; Soulby A; Evin GM; Scarr E
Schizophr Res; 2008 Dec; 106(2-3):229-36. PubMed ID: 18790604
[TBL] [Abstract][Full Text] [Related]
10. Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder.
Cannon DM; Carson RE; Nugent AC; Eckelman WC; Kiesewetter DO; Williams J; Rollis D; Drevets M; Gandhi S; Solorio G; Drevets WC
Arch Gen Psychiatry; 2006 Jul; 63(7):741-7. PubMed ID: 16818863
[TBL] [Abstract][Full Text] [Related]
11. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
Lange KW; Wells FR; Jenner P; Marsden CD
J Neurochem; 1993 Jan; 60(1):197-203. PubMed ID: 8417140
[TBL] [Abstract][Full Text] [Related]
12. Lower levels of TRAF1 in Brodmann's area 24, but not 46, in bipolar disorders are not detectable in major depressive disorders.
Dean B; Seymour N; Gibbons A
J Affect Disord; 2024 Jul; 356():316-322. PubMed ID: 38583598
[TBL] [Abstract][Full Text] [Related]
13. Changes in levels of cortical metabotropic glutamate 2 receptors with gender and suicide but not psychiatric diagnoses.
Dean B; Duncan C; Gibbons A
J Affect Disord; 2019 Feb; 244():80-84. PubMed ID: 30326345
[TBL] [Abstract][Full Text] [Related]
14. An investigation into nicotinic receptor involvement in mood disorders uncovers novel depression candidate genes.
Gibbons A; McPherson K; Gogos A; Dean B
J Affect Disord; 2021 Jun; 288():154-160. PubMed ID: 33895417
[TBL] [Abstract][Full Text] [Related]
15. Functional coupling of M
Odagaki Y; Kinoshita M; Meana JJ; Callado LF; García-Sevilla JA
Eur Arch Psychiatry Clin Neurosci; 2020 Oct; 270(7):869-880. PubMed ID: 31807862
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid composition of the postmortem prefrontal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder.
Hamazaki K; Maekawa M; Toyota T; Dean B; Hamazaki T; Yoshikawa T
Psychiatry Res; 2015 Jun; 227(2-3):353-9. PubMed ID: 25858798
[TBL] [Abstract][Full Text] [Related]
17. Altered M(1) muscarinic acetylcholine receptor (CHRM1)-Galpha(q/11) coupling in a schizophrenia endophenotype.
Salah-Uddin H; Scarr E; Pavey G; Harris K; Hagan JJ; Dean B; Challiss RA; Watson JM
Neuropsychopharmacology; 2009 Aug; 34(9):2156-66. PubMed ID: 19404243
[TBL] [Abstract][Full Text] [Related]
18. Chronic treatment with first or second generation antipsychotics in rodents: effects on high affinity nicotinic and muscarinic acetylcholine receptors in the brain.
Terry AV; Gearhart DA; Mahadik SP; Warsi S; Waller JL
Neuroscience; 2006 Jul; 140(4):1277-87. PubMed ID: 16626873
[TBL] [Abstract][Full Text] [Related]
19. Lower [3H]LY341495 binding to mGlu2/3 receptors in the anterior cingulate of subjects with major depressive disorder but not bipolar disorder or schizophrenia.
McOmish CE; Pavey G; Gibbons A; Hopper S; Udawela M; Scarr E; Dean B
J Affect Disord; 2016 Jan; 190():241-248. PubMed ID: 26521087
[TBL] [Abstract][Full Text] [Related]
20. Changes in cortical N-methyl-D-aspartate receptors and post-synaptic density protein 95 in schizophrenia, mood disorders and suicide.
Dean B; Gibbons AS; Boer S; Uezato A; Meador-Woodruff J; Scarr E; McCullumsmith RE
Aust N Z J Psychiatry; 2016 Mar; 50(3):275-83. PubMed ID: 26013316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
